Invivyd Inc (NAS:IVVD)
$ 1.385 0.095 (7.36%) Market Cap: 165.25 Mil Enterprise Value: -33.71 Mil PE Ratio: 0 PB Ratio: 0.92 GF Score: 22/100

Invivyd Inc at Jefferies Healthcare Conference Transcript

Jun 09, 2023 / 03:30PM GMT
Release Date Price: $1.3 (-3.70%)
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

All right. Thank you. Good morning. Thank you for joining us on another great session here for Jefferies Healthcare Conference. Very happy to have the CEO of Invivyd, Dave Hering up here with us. We have a nice introduction of presentation of a few slides, tell us a little bit about the story, and I certainly have lots of questions to ask, and we'll have a nice fireside.

David Hering
Invivyd, Inc. - CEO & Director

All right. Thanks, Michael. It's great to be here. Yes, I think just starting for our legal folks, a whole bunch of forward-looking statements. All is posted on our website as well. And one of the things I think I wanted to start with is I get this question frequently about, okay, we're now into year 3 plus of COVID-19. We've got vaccines, we've got oral antivirals. What really is the unmet need? And what are you trying to solve?

And really there's a multitude of patients that we still see have a huge need related to COVID therapeutics and one that is, in particular

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot